Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Mar 17;28(8):2536–2551. doi: 10.1038/s41418-021-00769-0

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s), under exclusive licence to ADMC Associazione Differenziamento e Morte Cellulare 2021

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Fig. 5 — a Representative immunohistochemical staining (IHC) of cortical renal tissues from the mice after ischemia reperfusion (IR) or sham treatment. The experiment was repeated three times, independently, with similar results. b Representative immunohistochemical staining (IHC) of liver cancer samples. The experiment was repeated twice, independently, with similar results. c Dot plot depicting the relevance of the signal intensity of FAR1 and 4-HNE IHC staining in the indicated liver cancer samples. d FAR1 signaling intensity in para-cancer and liver cancer tiusses indicates FAR1 is lower expressed in liver cancer tissues. e Representative immunohistochemical staining (IHC) of FAR1 and 4-HNE in human breast cancer samples. The experiment was repeated twice, independently, with similar results. f Dot plot depicting the relevance of the signal intensity of FAR1 and 4-HNE IHC staining in the breast cancer samples.